KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 98 filers reported holding KRONOS BIO INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,791 | -24.4% | 178,301 | 0.0% | 0.00% | – |
| Q2 2023 | $306,678 | -73.0% | 178,301 | -77.1% | 0.00% | – |
| Q1 2023 | $1,137,928 | -52.0% | 779,403 | -46.7% | 0.00% | – |
| Q4 2022 | $2,368,478 | -3.8% | 1,462,024 | +98.9% | 0.00% | – |
| Q3 2022 | $2,463,000 | -6.0% | 735,099 | +2.2% | 0.00% | – |
| Q2 2022 | $2,619,000 | -81.2% | 719,529 | -62.6% | 0.00% | -100.0% |
| Q1 2022 | $13,928,000 | -30.5% | 1,926,399 | +30.5% | 0.00% | 0.0% |
| Q4 2021 | $20,054,000 | +46.7% | 1,475,619 | +126.3% | 0.00% | 0.0% |
| Q3 2021 | $13,667,000 | +5.1% | 652,030 | +20.1% | 0.00% | 0.0% |
| Q2 2021 | $13,006,000 | +98.2% | 543,044 | +142.2% | 0.00% | – |
| Q1 2021 | $6,562,000 | -2.2% | 224,205 | -0.2% | 0.00% | – |
| Q4 2020 | $6,709,000 | – | 224,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $4,037,358 | 5.52% |
| Omega Fund Management, LLC | 3,818,283 | $5,574,693 | 3.64% |
| Nextech Invest Ltd. | 1,451,537 | $2,119,244 | 0.88% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,895,020 | 0.70% |
| Privium Fund Management (UK) Ltd | 292,182 | $455,804 | 0.36% |
| CM Management, LLC | 180,000 | $263 | 0.31% |
| Artal Group S.A. | 1,542,954 | $2,253 | 0.13% |
| Alphabet Inc. | 1,438,232 | $2,099,819 | 0.12% |
| Perceptive Advisors | 1,752,745 | $2,558,131 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 406,362 | $593 | 0.06% |